Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Apimeds Pharmaceuticals US, Inc. (APUS) had Weighted-Average Shares Outstanding (Diluted) of 7.90M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.40M |
|
-- |
|
-- |
|
$0.36M |
|
$-0.36M |
|
$-0.04M |
|
$-0.40M |
|
$-0.40M |
|
$-0.40M |
|
$-0.40M |
|
$-0.40M |
|
$-0.40M |
|
$-0.36M |
|
$-0.36M |
|
7.90M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
7.90M |
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$0.26M |
|
-- |
|
-- |
|
$0.26M |
|
$1.77M |
|
$0.25M |
|
$0.25M |
|
$2.02M |
|
$-1.76M |
|
$-1.76M |
|
$-1.76M |
|
7.90M |
|
| Cash Flow Statement Financials | |
$-0.02M |
|
-- |
|
$0.27M |
|
$0.00M |
|
$0.25M |
|
$0.25M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.15 |
|
-- |
|
-- |
|
-0.17 |
|
-0.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
22.86% |
|
22.86% |
|
-154.83% |
|
26.64% |
|
$-0.22 |
|
$-0.00 |
|
$-0.00 |
|